A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Repertaxin in the Prevention of Primary Graft Dysfunction After Lung Transplantation

Trial Profile

A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Repertaxin in the Prevention of Primary Graft Dysfunction After Lung Transplantation

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Jan 2015

At a glance

  • Drugs Reparixin (Primary)
  • Indications Reperfusion injury
  • Focus Therapeutic Use
  • Sponsors Dompe Spa
  • Most Recent Events

    • 20 Jun 2014 New trial record
    • 26 Nov 2008
    • 22 Sep 2006
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top